GILD241213P95000
- 2.54
- 0.000.00%
Gilead Sciences Newsroom
Market Falls Thursday, Producer Inflation Grows, and Tech Pulls Back From Records | LiveStock
CADL Stock Soars as Phase III Prostate Cancer Study Meets Primary Goal
Is Gilead Sciences (GILD) Stock Undervalued Right Now?
Piper Sandler Maintains Gilead Sciences(GILD.US) With Buy Rating, Maintains Target Price $105
Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It
A Quick Look at Today's Ratings for Gilead Sciences(GILD.US), With a Forecast Between $99 to $115
Looking For Yields: IDACORP, Gilead Sciences and Fifth Third Bancorp Are Consistent Moneymakers
Gilead Sciences (GILD) Gets a Buy From Piper Sandler
Gilead Sciences To Go Ex-Dividend On December 13th, 2024 With 0.77 USD Dividend Per Share
Gilead Sciences Price Target Maintained With a $80.00/Share by Cantor Fitzgerald
Market Climbs on CPI Inflation and Likelihood of Rate Cuts | Livestock
Express News | RBC Capital Reiterates Sector Perform on Gilead Sciences, Maintains $84 Price Target
Gilead Sciences Hits 4-week High
Gilead Sciences (GILD) Receives a Buy From Jefferies
A Quick Look at Today's Ratings for Gilead Sciences(GILD.US), With a Forecast Between $105 to $125
Today's Analyst Rating | Broadcom Price Target Raised to $205 by Citi, Oracle Price Target Raised to $210 by UBS
Express News | Gilead : Leerink Partners Raises Target Price to $99 From $96
Gilead Sciences' Strategic Focus on Lenacapavir and Lifecycle Management Drives Buy Rating
BofA Restarts Coverage of 11 Large-cap Biopharmas
Unusual Options Activity: AI, MSTR and Others Attract Market Bets, AI V/OI Ratio Reaches 249.3